Balance Sheet APT Medical Inc.

Equities

688617

CNE100004C45

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. Other stock markets 11/12/2025			5-day change	1st Jan Change
232.55 ^CNY	-3.20%		-3.83%	-9.44%

12-10	APT Medical to Buy Back up to 250 Million Yuan of Shares	MT
12-10	APT Medical Projects Nearly 104 Million Yuan in 2026 Related-Party Transactions	MT

2606834443b24a313c.cYzwD19bg68EhI922q2x5MmnbeXZ9614Ra7vQ0jzdAM.H86AeQso5sFxzskyqN7eraGRBa-YjfsUIe3XEC-aQ0clwsg6PSLZxjLU-A

Published financial data: APT MEDICAL INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	478M	823M	1.2B	1.64B	2.05B
Other Revenues, Total	1.5M	5.82M	11.55M	8.49M	16.62M
Total Revenues	479M	829M	1.22B	1.65B	2.07B
Cost of Goods Sold, Total	142M	259M	354M	486M	580M
Gross Profit	337M	570M	862M	1.16B	1.49B
Selling General & Admin Expenses, Total	153M	250M	308M	387M	464M
Provision for Bad Debts	283K	-511K	790K	-178K	2.22M
R&D Expenses	71.9M	135M	175M	238M	291M
Other Operating Expenses	6.14M	8.14M	13.75M	14.52M	15.22M
Other Operating Expenses, Total	232M	393M	497M	639M	772M
Operating Income	106M	177M	365M	525M	714M
Interest Expense, Total	-1.41M	-1.63M	-1.45M	-3.69M	-2.01M
Interest And Investment Income	1.21M	13.26M	23.94M	27.74M	25.23M
Net Interest Expenses	-207K	11.64M	22.49M	24.05M	23.23M
Currency Exchange Gains (Loss)	-431K	-1M	1.17M	2.66M	2.83M
Other Non Operating Income (Expenses)	-334K	-499K	-490K	-35.61K	-817K
EBT, Excl. Unusual Items	105M	187M	388M	552M	739M
Impairment of Goodwill	-	-	-	-3.84M	-
Gain (Loss) On Sale Of Investments	-67.73K	21.72M	342K	-	-16.7M
Gain (Loss) On Sale Of Assets	-231K	-51.8K	56.21K	11.97M	253K
Asset Writedown	-	-3.5M	-10.68M	-123K	-833K
Other Unusual Items	16.83M	16.58M	17.25M	36.83M	24.42M
EBT, Incl. Unusual Items	121M	222M	395M	596M	746M
Income Tax Expense	17.02M	26.7M	54.98M	74.24M	87.8M
Earnings From Continuing Operations	104M	195M	340M	522M	658M
Net Income to Company	104M	195M	340M	522M	658M
Minority Interest	6.58M	13.07M	17.86M	11.79M	14.98M
Net Income - (IS)	111M	208M	358M	534M	673M
Net Income to Common Incl Extra Items	111M	208M	358M	534M	673M
Net Income to Common Excl. Extra Items	111M	208M	358M	534M	673M
Per Share Items
Net EPS - Basic	1.06	1.52	2.56	3.82	4.8
Basic EPS - Continuing Operations	1.06	1.52	2.56	3.82	4.8
Basic Weighted Average Shares Outstanding	105M	137M	140M	140M	140M
Net EPS - Diluted	1.06	1.51	2.52	3.77	4.77
Diluted EPS - Continuing Operations	1.06	1.51	2.52	3.77	4.77
Diluted Weighted Average Shares Outstanding	105M	138M	142M	142M	141M
Normalized Basic EPS	0.69	0.95	1.86	2.55	3.4
Normalized Diluted EPS	0.69	0.94	1.83	2.52	3.38
Dividend Per Share	0.24	0.48	0.78	0.95	1.21
Payout Ratio	1.28	15.97	19.28	21.02	19.9
Supplemental Items
EBITDA	125M	204M	405M	580M	790M
EBITA	108M	177M	367M	528M	719M
EBIT	106M	177M	365M	525M	714M
EBITDAR	128M	205M	406M	581M	796M
Total Revenues (As Reported)	479M	829M	1.22B	1.65B	2.07B
Effective Tax Rate - (Ratio)	14.04	12.05	13.91	12.45	11.77
Total Current Taxes	17.33M	34.9M	55.62M	79.14M	103M
Total Deferred Taxes	-307K	-8.2M	-642K	-4.9M	-15.13M
Normalized Net Income	72.01M	130M	260M	357M	477M
Interest Capitalized	131K	82.6K	-	-	-
Interest on Long-Term Debt	-	522K	436K	693K	539K
Supplemental Operating Expense Items
Marketing Expenses	21.01M	33M	41.59M	46.16M	57.73M
Selling and Marketing Expenses	114M	195M	241M	305M	373M
General and Administrative Expenses	39.56M	55.12M	66.55M	82.26M	91.52M
Research And Development Expense From Footnotes	71.9M	135M	175M	238M	291M
Net Rental Expense, Total	2.3M	741K	726K	933K	5.63M
Imputed Operating Lease Interest Expense	321K	237K	170K	387K	1.79M
Imputed Operating Lease Depreciation	1.98M	505K	556K	547K	3.84M
Stock-Based Comp., R&D Exp. (Total)	-	9.17M	11.43M	8.96M	3.34M
Stock-Based Comp., S&M Exp. (Total)	-	4.06M	4.09M	3.46M	1.57M
Stock-Based Comp., G&A Exp. (Total)	-	3.96M	4.63M	5.07M	1.92M
Stock-Based Comp., Other (Total)	-	971K	1.6M	829K	408K
Total Stock-Based Compensation	-	18.17M	21.75M	18.32M	7.24M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	120M	310M	251M	1.28B	1.08B
Trading Asset Securities, Total	-	914M	881M	60M	-
Total Cash And Short Term Investments	120M	1.22B	1.13B	1.34B	1.08B
Accounts Receivable, Total	43.72M	34.01M	47.15M	41.78M	83.29M
Other Receivables	5.97M	13.45M	14.14M	8.76M	20.45M
Total Receivables	49.69M	47.46M	61.29M	50.54M	104M
Inventory	145M	263M	338M	328M	399M
Other Current Assets, Total	34.96M	19.15M	26.01M	41.18M	32.54M
Total Current Assets	350M	1.55B	1.56B	1.76B	1.62B
Gross Property Plant And Equipment	229M	363M	466M	668M	940M
Accumulated Depreciation	-73.51M	-105M	-147M	-204M	-268M
Net Property Plant And Equipment	155M	259M	320M	464M	672M
Long-term Investments	42.81M	121M	178M	160M	179M
Goodwill	-	-	-	48.13M	48.13M
Other Intangibles, Total	32.47M	32.38M	38.92M	83M	402M
Deferred Tax Assets Long-Term	1.62M	9.82M	12.64M	10.73M	27.44M
Deferred Charges Long-Term	1.62M	7.41M	5.09M	5.95M	3.4M
Other Long-Term Assets, Total	4.82M	30.24M	114M	44.83M	32.55M
Total Assets	589M	2.01B	2.23B	2.57B	2.98B
Liabilities
Accounts Payable, Total	8.19M	18M	34.65M	29.56M	46.32M
Accrued Expenses, Total	62.16M	94.76M	119M	161M	192M
Short-term Borrowings	10.5M	16M	30M	70M	-
Current Portion of Long-Term Debt	5M	6.09M	7.27M	1.18M	591K
Current Portion of Leases	-	7.46M	6.26M	10.1M	5.83M
Current Income Taxes Payable	3.38M	9.35M	13.3M	19.86M	27.1M
Unearned Revenue Current, Total	16.71M	32.32M	38.65M	44.4M	45.66M
Other Current Liabilities	3.48M	10.55M	163M	252M	88.39M
Total Current Liabilities	109M	195M	412M	588M	406M
Long-Term Debt	23.59M	10.23M	1.77M	591K	-
Long-Term Leases	-	6.8M	7.29M	7.99M	4.87M
Unearned Revenue Non Current	5.62M	7.3M	7.06M	8.74M	11.26M
Deferred Tax Liability Non Current	-	3.16M	6.92M	5.49M	2.74M
Other Non Current Liabilities	-	-	-	-	1.02M
Total Liabilities	139M	222M	435M	611M	426M
Common Stock, Total	50M	66.67M	66.67M	66.86M	97.39M
Additional Paid In Capital	159M	1.27B	1.01B	724M	785M
Retained Earnings	251M	425M	717M	1.14B	1.68B
Treasury Stock	-	-	-59.99M	-59.99M	-59.99M
Comprehensive Income and Other	-8.21K	17.89M	27.22M	34.96M	9.6M
Total Common Equity	460M	1.78B	1.76B	1.91B	2.52B
Minority Interest	-10.27M	12.95M	27.75M	54.86M	38.5M
Total Equity	450M	1.79B	1.79B	1.96B	2.55B
Total Liabilities And Equity	589M	2.01B	2.23B	2.57B	2.98B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	105M	140M	140M	140M	141M
ECS Total Common Shares Outstanding	105M	140M	140M	140M	141M
Book Value / Share	4.38	12.69	12.64	13.63	17.9
Tangible Book Value	428M	1.75B	1.72B	1.78B	2.07B
Tangible Book Value Per Share	4.07	12.45	12.36	12.69	14.7
Total Debt	39.09M	46.58M	52.59M	89.86M	11.29M
Net Debt	-81.25M	-1.18B	-1.08B	-1.25B	-1.07B
Debt Equivalent Oper. Leases	18.42M	5.93M	5.81M	7.47M	45.04M
Minority Interest, Total (Incl. Fin. Div)	-10.27M	12.95M	27.75M	54.86M	38.5M
Equity Method Investments, Total	12.81M	57.27M	84.83M	38.66M	101M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	99.49M	174M	218M	201M	221M
Inventories - Work In Process, Total	9.94M	32.18M	47.84M	56M	70.87M
Inventories - Finished Goods, Total	26.73M	61.22M	71.58M	82.72M	121M
Inventories - Others	9.4M	2.43M	4.99M	3.29M	4.39M
Buildings, Total	69.27M	81.94M	150M	173M	262M
Machinery, Total	142M	224M	277M	403M	591M
Full Time Employees	983	1.51K	1.74K	2.16K	2.56K
Accumulated Allowance for Doubtful Accounts (Supple)	3.22M	2.64M	3.45M	3.28M	5.44M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	111M	208M	358M	534M	673M
Depreciation & Amortization - CF	17.5M	32.43M	45.96M	60.38M	81.06M
Amortization of Goodwill and Intangible Assets - (CF)	2.31M	750K	1.56M	3.63M	5.65M
Depreciation & Amortization, Total	19.81M	33.18M	47.52M	64.01M	86.71M
Amortization of Deferred Charges, Total - (CF)	934K	1.37M	3.96M	3.88M	4.33M
(Gain) Loss From Sale Of Asset	-336	-16.58K	-56.21K	-10.81M	-253K
(Gain) Loss on Sale of Investments - (CF)	67.73K	-32.82M	-21.09M	-23.13M	3.53M
Asset Writedown & Restructuring Costs	239K	9.81M	10.68M	3.97M	833K
Provision for Credit Losses	470K	-	-	-	-
Provision and Write-off of Bad Debts	-	-511K	790K	-178K	2.22M
Other Operating Activities, Total	-5.32M	-10.11M	-13.45M	906K	303K
Change In Accounts Receivable	25.33M	4.3M	-23.17M	20M	-74.73M
Change In Inventories	-2.44M	-124M	-72.59M	11.22M	-79.29M
Change In Accounts Payable	-477K	82.51M	61.71M	68.9M	134M
Change In Deferred Taxes	-307K	-8.2M	939K	-4.9M	-15.13M
Change in Other Net Operating Assets	-849K	18.17M	14.19M	21.28M	7.24M
Cash from Operations	148M	181M	367M	689M	743M
Capital Expenditure	-44.2M	-167M	-143M	-202M	-650M
Sale of Property, Plant, and Equipment	12K	36.03K	229K	12.67M	604K
Cash Acquisitions	-	-	-	-46.37M	-
Investment in Marketable and Equity Securities, Total	-30M	-948M	-39.16M	798M	23.84M
Other Investing Activities, Total	74.92M	4.93M	47.61M	19.82M	8.01M
Cash from Investing	730K	-1.11B	-135M	582M	-618M
Short Term Debt Issued, Total	-	-	-	-	12.5M
Long-Term Debt Issued, Total	16.41M	48.5M	82.6M	70M	-
Total Debt Issued	16.41M	48.5M	82.6M	70M	12.5M
Short Term Debt Repaid, Total	-	-	-	-	-5.04M
Long-Term Debt Repaid, Total	-115M	-30.27M	-84.16M	-49.62M	-82.74M
Total Debt Repaid	-115M	-30.27M	-84.16M	-49.62M	-87.78M
Issuance of Common Stock	-	1.2B	19M	34.67M	78.53M
Repurchase of Common Stock	-	-	-59.99M	-	-
Common Dividends Paid	-1.41M	-33.19M	-69.01M	-112M	-134M
Common & Preferred Stock Dividends Paid	-1.41M	-33.19M	-69.01M	-112M	-134M
Other Financing Activities, Total	-1.43M	-64.99M	-183M	-189M	-177M
Cash from Financing	-102M	1.12B	-295M	-246M	-308M
Foreign Exchange Rate Adjustments	-527K	-1.02M	958K	2.84M	-13M
Net Change in Cash	46.83M	189M	-60.71M	1.03B	-195M
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Cash Income Tax Paid (Refund)	52.64M	78.34M	146M	204M	251M
Levered Free Cash Flow	38.85M	-34.12M	265M	354M	-330M
Unlevered Free Cash Flow	39.73M	-33.1M	266M	356M	-329M
Change In Net Working Capital	2.85M	28.87M	-108M	-144M	223M
Net Debt Issued / Repaid	-98.78M	18.23M	-1.56M	20.38M	-75.28M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	11.49	8.49	10.76	13.67	16.06
Return on Total Capital	13.57	9.49	12.39	16.84	19.32
Return On Equity %	26.18	17.39	18.99	27.82	29.14
Return on Common Equity	27.35	18.58	20.22	29.09	30.44
Margin Analysis
Gross Profit Margin %	70.35	68.74	70.89	70.54	71.93
SG&A Margin	31.98	30.22	25.29	23.45	22.48
EBITDA Margin %	26.17	24.65	33.3	35.15	38.25
EBITA Margin %	22.52	21.41	30.14	32.03	34.82
EBIT Margin %	22.04	21.32	30.02	31.81	34.54
Income From Continuing Operations Margin %	21.73	23.51	27.97	31.64	31.86
Net Income Margin %	23.11	25.09	29.44	32.35	32.59
Net Avail. For Common Margin %	23.11	25.09	29.44	32.35	32.59
Normalized Net Income Margin	15.02	15.67	21.42	21.6	23.08
Levered Free Cash Flow Margin	8.1	-4.12	21.81	21.45	-16
Unlevered Free Cash Flow Margin	8.29	-3.99	21.89	21.59	-15.94
Asset Turnover
Asset Turnover	0.83	0.64	0.57	0.69	0.74
Fixed Assets Turnover	3.32	4	4.2	4.21	3.64
Receivables Turnover (Average Receivables)	10.53	21.17	29.68	36.92	32.77
Inventory Turnover (Average Inventory)	0.99	1.27	1.18	1.46	1.59
Short Term Liquidity
Current Ratio	3.2	7.98	3.78	2.99	3.98
Quick Ratio	1.55	6.53	2.9	2.36	2.92
Operating Cash Flow to Current Liabilities	1.35	0.93	0.89	1.17	1.83
Days Sales Outstanding (Average Receivables)	34.76	17.24	12.3	9.89	11.17
Days Outstanding Inventory (Average Inventory)	370.94	287.77	309.9	249.98	229.51
Average Days Payable Outstanding	22.12	12.68	22.41	24.61	25.02
Cash Conversion Cycle (Average Days)	383.58	292.33	299.78	235.25	215.66
Long Term Solvency
Total Debt/Equity	8.69	2.6	2.94	4.58	0.44
Total Debt / Total Capital	7.99	2.53	2.85	4.38	0.44
LT Debt/Equity	5.24	0.95	0.51	0.44	0.19
Long-Term Debt / Total Capital	4.82	0.93	0.49	0.42	0.19
Total Liabilities / Total Assets	23.55	11.03	19.54	23.75	14.29
EBIT / Interest Expense	74.77	108.65	251.42	142.29	355.86
EBITDA / Interest Expense	88.79	129.06	284.15	159.64	399.11
(EBITDA - Capex) / Interest Expense	57.51	26.13	185.51	104.87	74.83
Total Debt / EBITDA	0.31	0.22	0.13	0.15	0.01
Net Debt / EBITDA	-0.65	-5.61	-2.62	-2.12	-1.34
Total Debt / (EBITDA - Capex)	0.48	1.1	0.2	0.23	0.08
Net Debt / (EBITDA - Capex)	-1	-27.7	-4.01	-3.22	-7.13
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	18.68	72.85	46.74	35.71	25.18
Gross Profit, 1 Yr. Growth %	18.02	68.87	51.33	35.05	27.65
EBITDA, 1 Yr. Growth %	22.16	61.47	99	42.99	36.04
EBITA, 1 Yr. Growth %	20.29	62.8	107.46	43.89	35.88
EBIT, 1 Yr. Growth %	20.03	65.93	107.76	43.8	35.96
Earnings From Cont. Operations, 1 Yr. Growth %	33.45	87.01	74.57	53.5	26.05
Net Income, 1 Yr. Growth %	34.15	87.7	72.19	49.13	26.08
Normalized Net Income, 1 Yr. Growth %	21.22	78.12	101.59	36.87	33.73
Diluted EPS Before Extra, 1 Yr. Growth %	34.54	42.79	67.2	49.43	26.74
Accounts Receivable, 1 Yr. Growth %	-7.11	-22.2	38.62	-11.39	99.37
Inventory, 1 Yr. Growth %	1.7	81.21	28.37	-2.96	21.76
Net Property, Plant and Equip., 1 Yr. Growth %	16.25	66.81	23.65	45.18	44.59
Total Assets, 1 Yr. Growth %	4.93	241.95	10.58	15.59	15.85
Tangible Book Value, 1 Yr. Growth %	74.06	307.99	-1.22	2.99	16.34
Common Equity, 1 Yr. Growth %	31.69	286.25	-0.83	8.16	31.94
Cash From Operations, 1 Yr. Growth %	170.03	22.36	102.58	87.52	7.88
Capital Expenditures, 1 Yr. Growth %	-34.58	278.68	-14.44	41.08	221.86
Levered Free Cash Flow, 1 Yr. Growth %	-178.47	-185.88	-842.59	34.29	-193.57
Unlevered Free Cash Flow, 1 Yr. Growth %	-180.52	-182.24	-866.96	34.7	-192.61
Dividend Per Share, 1 Yr. Growth %	-	100	65.01	21.2	26.88
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	40.82	43.23	59.26	41.12	30.34
Gross Profit, 2 Yr. CAGR %	42.42	41.17	59.86	42.96	31.3
EBITDA, 2 Yr. CAGR %	118.74	41.01	78.93	68.84	39.57
EBITA, 2 Yr. CAGR %	150.4	40.6	83.39	72.95	39.94
EBIT, 2 Yr. CAGR %	148.57	41.67	85.14	72.85	39.83
Earnings From Cont. Operations, 2 Yr. CAGR %	149.97	57.98	80.68	63.7	39.1
Net Income, 2 Yr. CAGR %	126.92	58.68	79.78	60.25	37.12
Normalized Net Income, 2 Yr. CAGR %	111.84	47.83	89.03	66.11	35.29
Diluted EPS Before Extra, 2 Yr. CAGR %	127.23	38.6	54.51	58.06	37.59
Accounts Receivable, 2 Yr. CAGR %	31.17	-14.99	3.85	10.83	32.91
Inventory, 2 Yr. CAGR %	34.44	35.76	52.52	11.62	8.7
Net Property, Plant and Equip., 2 Yr. CAGR %	24.1	39.25	43.62	33.98	44.88
Total Assets, 2 Yr. CAGR %	34.42	89.43	94.45	13.05	15.72
Tangible Book Value, 2 Yr. CAGR %	26.16	166.49	100.75	0.86	9.46
Common Equity, 2 Yr. CAGR %	30.61	125.53	95.71	3.56	19.46
Cash From Operations, 2 Yr. CAGR %	182.07	81.77	57.44	94.9	42.23
Capital Expenditures, 2 Yr. CAGR %	17.17	57.39	80	9.86	113.09
Levered Free Cash Flow, 2 Yr. CAGR %	61.65	-16.99	158.38	214.83	11.97
Unlevered Free Cash Flow, 2 Yr. CAGR %	64.41	-18.1	157.14	220.45	11.56
Dividend Per Share, 2 Yr. CAGR %	-	-	81.67	41.42	24.01
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	46.28	50.77	44.39	50.99	35.59
Gross Profit, 3 Yr. CAGR %	47.36	50.74	44.48	51.12	37.66
EBITDA, 3 Yr. CAGR %	85.94	98.22	57.98	66.14	57.18
EBITA, 3 Yr. CAGR %	107.44	117.6	59.84	69.26	59.67
EBIT, 3 Yr. CAGR %	106.54	117.8	60.65	70.18	59.56
Earnings From Cont. Operations, 3 Yr. CAGR %	56.7	126.92	63.33	71.12	50.04
Net Income, 3 Yr. CAGR %	47.55	113.01	63.06	68.92	47.94
Normalized Net Income, 3 Yr. CAGR %	40.06	100.76	63.67	69.75	54.53
Diluted EPS Before Extra, 3 Yr. CAGR %	47.65	94.63	47.55	52.8	46.83
Accounts Receivable, 3 Yr. CAGR %	13.39	10.21	0.06	-1.5	34.79
Inventory, 3 Yr. CAGR %	49.1	48.51	33.25	31.18	14.9
Net Property, Plant and Equip., 3 Yr. CAGR %	30.8	36.96	33.85	44.14	37.43
Total Assets, 3 Yr. CAGR %	32.56	83.5	58.31	63.5	13.98
Tangible Book Value, 3 Yr. CAGR %	26.17	86.57	91.43	60.71	5.78
Common Equity, 3 Yr. CAGR %	29.05	87.48	71.5	60.61	12.27
Cash From Operations, 3 Yr. CAGR %	125.58	113.53	88.46	66.89	60.03
Capital Expenditures, 3 Yr. CAGR %	20.5	73.23	28.45	65.96	57.2
Levered Free Cash Flow, 3 Yr. CAGR %	-	31.9	74.98	107.32	109.94
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	31.07	75.37	106.87	111.7
Dividend Per Share, 3 Yr. CAGR %	-	-	-	58.74	36.4
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	51.34	46.83	38.6
Gross Profit, 5 Yr. CAGR %	-	-	52.24	47.58	39.05
EBITDA, 5 Yr. CAGR %	-	-	83.4	85.76	50.39
EBITA, 5 Yr. CAGR %	-	-	97.83	98.33	51.62
EBIT, 5 Yr. CAGR %	-	-	98	98.34	51.97
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	65.88	99.13	53.17
Net Income, 5 Yr. CAGR %	-	-	59.68	90.09	52.14
Normalized Net Income, 5 Yr. CAGR %	-	-	58.29	85.93	51.67
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	50.36	79.08	43.48
Accounts Receivable, 5 Yr. CAGR %	-	-	9.47	10.46	12.1
Inventory, 5 Yr. CAGR %	-	-	50.46	32.48	22.83
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	35.78	35.76	38.16
Total Assets, 5 Yr. CAGR %	-	-	54.51	51.18	39.66
Tangible Book Value, 5 Yr. CAGR %	-	-	51.93	45.88	53.08
Common Equity, 5 Yr. CAGR %	-	-	52.44	47.86	48.4
Cash From Operations, 5 Yr. CAGR %	-	-	95.36	105.87	68.4
Capital Expenditures, 5 Yr. CAGR %	-	-	41.48	44.39	57.28
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	88.52	46.18
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	89.19	46.17